Our Approach to R&D
The development of our therapeutics is based on our unique understanding of what occurs at the intersection of the human host and microbiome. Each of our compounds is designed to modulate specific molecular pathways in both human cells, as well as specific microbes, at the point of their interaction.
Distinct Modes of Action
Our approach works in three distinct ways: by interacting with the host immune system, by preventing the invasion of certain pathogens, and by encouraging the growth and metabolism of specific, beneficial bacteria.